DE2759395C2 - 4-Pyridylformimidoylglycyl-D-phenylglycin - Google Patents
4-Pyridylformimidoylglycyl-D-phenylglycinInfo
- Publication number
- DE2759395C2 DE2759395C2 DE2759395A DE2759395A DE2759395C2 DE 2759395 C2 DE2759395 C2 DE 2759395C2 DE 2759395 A DE2759395 A DE 2759395A DE 2759395 A DE2759395 A DE 2759395A DE 2759395 C2 DE2759395 C2 DE 2759395C2
- Authority
- DE
- Germany
- Prior art keywords
- radical
- phenylglycine
- pyridylformimidoylglycyl
- phenyl
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- FXYHMGFKNCQJTA-CQSZACIVSA-N (2R)-2-[[2-[[amino(pyridin-4-yl)methylidene]amino]acetyl]amino]-2-phenylacetic acid Chemical compound N1=CC=C(C=C1)C(=N)NCC(=O)N[C@H](C1=CC=CC=C1)C(=O)O FXYHMGFKNCQJTA-CQSZACIVSA-N 0.000 title claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- -1 4-pyridylformimidoylamino-acetamido Chemical group 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YZOSWXATEQPYKN-SECBINFHSA-N (2r)-2-[(2-chloroacetyl)amino]-2-phenylacetic acid Chemical compound ClCC(=O)N[C@@H](C(=O)O)C1=CC=CC=C1 YZOSWXATEQPYKN-SECBINFHSA-N 0.000 description 2
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 description 2
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IPOAIJXWJYUYLP-SECBINFHSA-N (2r)-2-[(2-aminoacetyl)amino]-2-phenylacetic acid Chemical compound NCC(=O)N[C@@H](C(O)=O)C1=CC=CC=C1 IPOAIJXWJYUYLP-SECBINFHSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- TXDMMXRBAMKTPP-UHFFFAOYSA-N 2-[[amino(pyridin-4-yl)methylidene]amino]acetic acid Chemical compound OC(=O)CN=C(N)C1=CC=NC=C1 TXDMMXRBAMKTPP-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- 229910052740 iodine Chemical group 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- NJHSZWGAZDIXPZ-UHFFFAOYSA-N methyl pyridine-4-carboximidate Chemical compound COC(=N)C1=CC=NC=C1 NJHSZWGAZDIXPZ-UHFFFAOYSA-N 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2224—Compounds having one or more tin-oxygen linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
NH
NHCH2CONHCHCO,H
IO
15
20
25 Die erfindungsgemäße Verbindung stellt ein sehr
brauchbares Zwischenprodukt zur Herstellung der antibakteriell wirksamen 6-[D-2-Phenyl-2-(4-pyridylformimidoylamino-acetamidoj-acetamidoj-penicillansäure
durch Acylierung von 6-Aminopenicillansäure oder deren Derivaten dar.
Die erfindungsgemäße Verbindung kann aus D-Phenylglycin durch Umsetzung mit Chloracetylchlorid,
Behandlung des so erhaltenen Chloracetyl-D-phenylglycin
mit konzentrierter wäßriger Ammoniumhydroxidlösung und Umsetzung des auf diese Weise erhaltenen
Glycyl-D-phenylglycin mit 4-Pyridylformimidomethylether
erhalten werden.
Die bisher verwendeten Verfahren zur Synthese von Penicillinen hängen weitgehend ab von der Zugänglichkeit
der Ausgangsmaterialien und der Struktur des Endproduktes. Mit Hilfe des erfindungsgemäßen 4-Pyridylformimidoylglycyl-D-phenylglycin
kann man die 6-[D-2-Phenyl-2^(4-pyridylformimidoyIamino-acetamido)-acetamido]-penicillansäure,
ein antibakterielles Mittel, bequem herstellen durch Kupplung mit S-Arninopenicillansäure
oder deren Derivaten.
6-[D-2-PhenyI-2-(4-pyridylformimidoylamino-acetamido)-acetamido]-penicillansäure
hat die Formel
NH
N J^C—NHCH2CONHCHCONH
jo CH3
(II)
J5 CO2H
und wurde erstmals in der US 39 51 952 beschrieben.
Nach dieser Patentschrift erfolgt ihre Herstellung durch Acylierung von D-a-Aminobenzylpeniciliin mit 4-Pyridylformimidoylaminoessigsäure in Form des Säurechlorides oder eines aktivierten Esters oder durch
Umsetzung von 4-Pyridylformimido-methylester mit
6-[D-2-Phenyl-2-(aminoacetamido)-acetamido]-penicillansäure.
Mit Hilfe der erfindungsgemäßen Verbindung kann die 6-[D-2-Phenyl-2-(4-pyridylformimidoylamino-acetamido)-acetamido]-penicillansäure erhalten werden, indem man diese zunächst in ein 4-Pyridylformimidoylglycyl-D-phenylglycinderivat der allgemeinen Formel
NH O
Ii
- NHCH2CONHCHc X (III)
reste bedeuten, oder einen Rest der allgemeinen Formel
O
Il
R—C—O—
worin Π einen Alkoxyrest mit 1 bis 4 Kohlenstoffatomen 4Ϊ oder den t-Butylrest bedeutet, darstellt, und dieses
Derivat dann mit einer 6-Aminopenicillansäure der allgemeinen Formel
H2N
(IV)
worin Z Wasserstoff oder eine der folgenden Schutzgruppen darstellt
a) einen Rest
umwandelt, worin X Chlor, den Phenoxy-, 4-Chlgrphenoxy-, 4-Nitrophenoxy-, Phenylthio-, 4-Chlorphenylthio-,
4-Nitrophenylthio-, 2-Pyridylthio-, N-Phthalimidoxy-,
N-Succinimidoxy- oder I-Benzotriazolyloxyrest, einen
Rest der Formel
O- -C(=NR')NHR"
worin R' und R" Cyclohexyl- oder N-Morpholinoethyl-
R.
— Ρ
worin Ri und R2 jeweils Alkylreste mit I bis 3 |
b) den 3,5-Di-t-butyl-4-hydroxybenzylrest,
c) einen Rest-CH2-Y, worin Y einen Rest
-CR3
worin R3 ein Phenylrest oder Alkylrest mit 1 bis 3
Kohlenstoffatomen ist, —CN oder einen Carbalkoxyrest mit 2 bis 4 Kohlenstoffatomen bedeutet,
d) einen Rest — N=CHR* worin R» einen Phenylrest
oder Alkylrest mit 1 bis 3 Kohlenstoffatomen bedeutet,
e) einen Rest Sn(RsK worin Rs einen Alkylrest mit 1
bis 4 Kohlenstoffatomen bedeutet,
Q einen Rest —CReRjRs, worin R* und R7 jeweils
Wasserstoff, Phenyl oder Methyl und Rg einen Phenyl-, 4-MethoxyphenyI-, 4-NitrophenyI- oder
Methylrest bedeuten, unter der Maßgabe, daß, wenn R6 und «v Methyl sind, R8 ebenfalls Methyl
bedeutet,
g) einen Rest -CH2CR9RiORn, worin R9 Brom, Chlor
oder Jod und Rio und Ri 1 jeweils Wasserstoff, Brom,
Chlor oder Jod bedeuten, oder
h) einen Rest Si(CH3)ZRiI worin R12 den Methyl- oder
6-Aminopenicillanoyloxyrest bedeutet,
in einem reaktionsinerten Lösungsmittel bei einem pH-Wert von etwa 3,5 bis 8 und einer Reaktionstemperatur von etwa 0 bis —15° C umsetzt und anschließend
die Schutzgruppe Z entfernt
Die Erfindung wird durch das folgende Beispiel erläutert:
Beispiel
4-PyridylformidoylglycyI-D-phenylglycin
Der pH-Wert eines Gemischs aus 1203 g D-Phenylglycin in 800 ml Wasser wird mit 6 n-wäßriger
Natriumhydroxidlösung auf 12 eingestellt, die resultierende klare Lösung wird mit 400 ml Benzol überschichtet und auf 5" C abgekühlt Dann werden langsam im
Verlauf von 45 Minuten unter kräftigem Rühren 277,2 g Chloracetylchlorid zugegeben. Die Temperatur wird
durch Kühlung bei 0 bis 3° C gehalten, der pH-Wert wird durch periodischen Zusatz von 6 η-wäßriger Natrium-
hydroxidlösung bei 12,0 gehalten. Nach beendeter Zugabe wird das Reaktionsgemisch noch eine Stunde
bei 5°C gerührt und dann mit 50%iger wäßriger Schwefelsäure auf pH 2 angesäuert Dann wird das
Reaktionsgemisch zweimal mit 500 ml Äthylactai
extrahiert die vereinigten Extrakte werden über Magnesiumsulfat getrocknet und bei vermindertem
Druck zur Trockene eingeengt Der Rückstand wird mit 40OmI kaltem Diäthyläther verrieben, filtriert und
getrocknet Dabei werden i30 g (72% Ausbeute) des
gewünschten Produkts erhalten.
Eine Lösung von Chloracetyl-D-phcnylglycin in
500 ml konzentrierter wäßriger Ammoniumhydroxidlö
sung (37%) wird über Nacht bei Raumtemperatur
gerührt. Dann wird die Lösung im Vakuum zur Trockne eingeengt und der Rückstand wird in Aceton aufgeschlämmt Der Niederschlag wird abfiltriert, mit Aceton
gewaschen und in 200 ml Methanol von 45° C eine
Stunde aufgeschlämmt Das rohe Glycyl-D-phenylglydn
wird abfiltriert und getrocknet Ausbeute 20,4 g.
Zu einer Suspension t1« rohen Dipeptids in 100 ml
Wasser und 100 ml Dimethylformamid wird 6 n-wäßrige Natriumhydroxidlösung bis zum pH-Wert 9,4 zugege
ben. Zu der resultierenden Lösung werden 20 g
Methyl-4-pyridyIformimidat in 100 ml Dimethylformamid zugesetzt und das Reaktionsgemisch wird 2
Stunden bei Raumtemperatur gerührt Dann wird das Gemisch mit 12 η-Salzsäure auf pH 5,7 angesäuert und
mit 200 ml Methylenchlorid gewaschen. Die wäßrige Lösung wird im Vakuum auf 100 ml eingeengt und mit
350 ml Methanol verdünnt Nach einstündigem Rühren wird der Niederschlag abfiltriert und in 150 ml
Dimethylformamid gelöst Geringe ungelöste Anteile
werden abfiltriert und das Filtrat wird mit 350 ml
Methanol verdünnt Nach einstündigen, Rühren wird der Niederschlag abfiltriert und getrocknet, dabei erhält
man 24,14 g (85%) des gewünschten Produkts.
Claims (1)
- Patentanspruch:4-Pyridylformimidoylglycyl-D-phenyIglycin der FormelNH/-C-NHCh2CONHCHCO1H (I)Die Erfindung betrifft die neue Verbindung 4-Pyridylformimidoylglycyl-D-phenylglycin der Formel
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69232376A | 1976-06-03 | 1976-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2759395B1 DE2759395B1 (de) | 1980-04-10 |
DE2759395C2 true DE2759395C2 (de) | 1980-12-11 |
Family
ID=24780106
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2724551A Expired DE2724551C3 (de) | 1976-06-03 | 1977-05-31 | Verfahren zur Herstellung von 6- [D-2-Phenyl-2-(4-pvridylformimidoylaminoacetamido)acetamido] -peniciUansäure |
DE2759395A Expired DE2759395C2 (de) | 1976-06-03 | 1977-05-31 | 4-Pyridylformimidoylglycyl-D-phenylglycin |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2724551A Expired DE2724551C3 (de) | 1976-06-03 | 1977-05-31 | Verfahren zur Herstellung von 6- [D-2-Phenyl-2-(4-pvridylformimidoylaminoacetamido)acetamido] -peniciUansäure |
Country Status (11)
Country | Link |
---|---|
US (1) | US4073780A (de) |
JP (1) | JPS52148094A (de) |
BE (1) | BE855325A (de) |
DE (2) | DE2724551C3 (de) |
DK (1) | DK206577A (de) |
ES (1) | ES458313A1 (de) |
FR (3) | FR2355019A1 (de) |
GB (2) | GB1540347A (de) |
IE (1) | IE45072B1 (de) |
LU (1) | LU77464A1 (de) |
NL (1) | NL7704353A (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2758000A1 (de) * | 1977-12-24 | 1979-07-05 | Hoechst Ag | Verfahren zur herstellung von penicillinen und cephalosporinen |
JPS5725973A (en) * | 1980-07-22 | 1982-02-10 | Tokyo Electric Co Ltd | Thermal label printer |
JPH06262950A (ja) * | 1993-03-10 | 1994-09-20 | Yamato Sangyo:Kk | 自動車のカバー装置 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3793451A (en) * | 1970-11-05 | 1974-02-19 | Monsanto Co | Insecticidal pyridylaminidinoureas |
US3950348A (en) * | 1971-12-30 | 1976-04-13 | Merck & Co., Inc. | Process for preparing e-pyridyl-4-methyloxycarbonyllysine |
BE794886A (fr) * | 1972-02-22 | 1973-08-02 | Pfizer | Acides 6-(alpha-(omega-guanidinoalcanoylamino)acylamino)-penicillaniques |
GB1418656A (en) * | 1972-08-02 | 1975-12-24 | Pfizer | 6-alpha-amidino-and imidoylaminoalkanoyl-amino-penicillanic acids |
-
1977
- 1977-02-24 US US05/771,773 patent/US4073780A/en not_active Expired - Lifetime
- 1977-04-21 NL NL7704353A patent/NL7704353A/xx not_active Application Discontinuation
- 1977-04-29 ES ES458313A patent/ES458313A1/es not_active Expired
- 1977-05-11 JP JP5419177A patent/JPS52148094A/ja active Pending
- 1977-05-11 DK DK206577A patent/DK206577A/da unknown
- 1977-05-31 DE DE2724551A patent/DE2724551C3/de not_active Expired
- 1977-05-31 DE DE2759395A patent/DE2759395C2/de not_active Expired
- 1977-06-01 LU LU77464A patent/LU77464A1/xx unknown
- 1977-06-02 IE IE1137/77A patent/IE45072B1/en unknown
- 1977-06-02 FR FR7716900A patent/FR2355019A1/fr active Granted
- 1977-06-02 GB GB35363/78A patent/GB1540347A/en not_active Expired
- 1977-06-02 GB GB23484/77A patent/GB1540346A/en not_active Expired
- 1977-06-02 BE BE178140A patent/BE855325A/xx unknown
- 1977-10-17 FR FR7731174A patent/FR2367748A1/fr active Granted
- 1977-10-17 FR FR7731173A patent/FR2367766A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
GB1540347A (en) | 1979-02-07 |
ES458313A1 (es) | 1978-02-16 |
BE855325A (fr) | 1977-12-02 |
FR2367748A1 (fr) | 1978-05-12 |
GB1540346A (en) | 1979-02-07 |
FR2367748B1 (de) | 1981-12-18 |
FR2367766B1 (de) | 1982-07-02 |
FR2367766A1 (fr) | 1978-05-12 |
DE2759395B1 (de) | 1980-04-10 |
DK206577A (da) | 1977-12-04 |
DE2724551B2 (de) | 1979-09-27 |
DE2724551A1 (de) | 1977-12-08 |
US4073780A (en) | 1978-02-14 |
FR2355019B1 (de) | 1982-07-02 |
FR2355019A1 (fr) | 1978-01-13 |
LU77464A1 (de) | 1979-01-19 |
DE2724551C3 (de) | 1980-06-12 |
NL7704353A (nl) | 1977-12-06 |
JPS52148094A (en) | 1977-12-08 |
IE45072L (en) | 1977-12-03 |
IE45072B1 (en) | 1982-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2324272A1 (de) | 3-methylencephalosporine | |
DE1445506A1 (de) | Verfahren zur Gewinnung von reinen alpha-Aminobenzylpenicillinen und neue antibakterielle Mittel | |
DE2165554A1 (de) | Verfahren zur herstellung von 1,2,4triazin-5-on-derivaten | |
DE2759395C2 (de) | 4-Pyridylformimidoylglycyl-D-phenylglycin | |
DE2160319B2 (de) | 3-Exomethylencepham-Verbindungen, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von 3-Methyl-Cephem-Derivaten | |
DE3035259C2 (de) | Cephalosporinverbindungen, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten | |
DE2822876C2 (de) | ||
DE1795720A1 (de) | Verfahren zur herstellung von 4und/oder 4,6-dihydroxy-pyrazolo-(3,4) pyrimidinen | |
DE1951012A1 (de) | Ester der 7-(alpha-Amino-alpha-phenylacctamido)-3-methyl-delta?-cephem-4-carbonsaeure | |
DE1189997B (de) | Verfahren zur Herstellung von Butadiencarbonsaeurepiperaziden | |
DE1901918A1 (de) | Penicilline und Verfahren zu ihrer Herstellung | |
CH627156A5 (de) | ||
CH474490A (de) | Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe | |
AT232196B (de) | Verfahren zur Herstellung von Penicillinen | |
AT336572B (de) | Verfahren zur herstellung von neuen alkylsulfonylaminoglycinen sowie deren salzen | |
DE1056132B (de) | Verfahren zur Herstellung von Thionothiolphosphorsaeureestern | |
DE2012955C3 (de) | Verfahren zur Herstellung von Desacetoxycephalosporinderivaten | |
DE1277857B (de) | Verfahren zur Herstellung von 1, 2-Dialkyl-indazolon-3-hydrazonen | |
DE1470244C (de) | 5-Sulfanilamido-pyridazon-(6)-derivate | |
AT340587B (de) | Verfahren zur herstellung neuer cephemderivate | |
DE1695493A1 (de) | Verfahren zur Herstellung von Indolyl-(3)-essigsaeureverbindungen | |
AT239243B (de) | Verfahren zur Herstellung von 2, 3-Dicyan-1, 4-dithia-anthrahydrochinon und -anthrachinon | |
AT226364B (de) | Verfahren zur Herstellung von neuen Penicillinderivaten | |
CH558319A (de) | Verfahren zur herstellung von neuen 1,3-diketonen. | |
CH646167A5 (de) | Verfahren zur herstellung von apovincaminsaeureestern. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OI | Miscellaneous see part 1 | ||
OI | Miscellaneous see part 1 | ||
OD | Request for examination | ||
8339 | Ceased/non-payment of the annual fee |